Calcium supplementation to reduce prostate cancer risk

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/00 (2006.01) A61K 31/194 (2006.01) A61K 31/44 (2006.01) A61K 33/06 (2006.01) A61K 33/08 (2006.01) A61K 33/10 (2006.01)

Patent

CA 2438426

A method for promoting prostate helath in a subject comprising administering a dose of calcium to the subject. Particularly provided is a method for reducing the risk of prostate carcinomas, comprising administering a dose of elemental calcium effective to reduce the risk of prostate cancer. In an example, 1200 mg of elemental calcium (supplied in 3000 mg of calcium carbonate) administered twice daily resulted in decreased risk of prostate cancer.

L'invention porte sur un procédé favorisant le bon état de la prostate consistant à administrer à un patient des doses de calcium, et en particulier sur un procédé réduisant les risques de carcinome de la prostate par administration de doses à cet effet de calcium élémentaire. A titre d'exemple, une dose biquotidienne de 1200 mg de calcium élémentaire (fournie dans 3000 mg de carbonate de calcium) entraîne une décroissance du risque de cancer de la prostate.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Calcium supplementation to reduce prostate cancer risk does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Calcium supplementation to reduce prostate cancer risk, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium supplementation to reduce prostate cancer risk will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1456587

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.